You can buy or sell Evogene and other stocks, options, ETFs, and crypto commission-free!
Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. Read More It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities. The company was founded by Amir Barzilay and Hagai Karchi in 2002 and is headquartered in Rehovot, Israel.
52 Week High
52 Week Low
Seeking AlphaMay 28
Evogene Ltd. CEO Ofer Haviv on Q1 2019 Results - Earnings Call Transcript
Evogene Ltd. (NASDAQ:EVGN) Q1 2019 Earnings Conference Call May 28, 2019 9:00 AM ET Company Participants Ofer Haviv - CEO Arnon Heyman - CEO, Canonic Dorit Kreiner - CFO Conference Call Participants Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's First Quarter 2019 Results Conference Call. All participants are at present in listen-only mode. Following management's formal presentation, instructions will be given for the question-and-answer session. [Operator Instructions...
Expected Aug 7, Pre-Market